id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2006-E-0319-0007,FDA,FDA-2006-E-0319,Certificate Extending Patent Term from U.S. Patent and Trademark Office to Foley & Lardner,Rule,Certificate Extending Patent Term,2007-10-23T04:00:00Z,2007,10,,,2025-12-18T20:19:20Z,,0,0,090000648045cbc0
FDA-2006-E-0319-0006,FDA,FDA-2006-E-0319,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2007-03-12T05:00:00Z,2007,3,,,2025-12-18T20:17:54Z,,0,0,090000648045cbbf
FDA-2006-E-0319-0005,FDA,FDA-2006-E-0319,Determination of Regulatory Review Period for Purposes of Patent Extension; IPLEX,Notice,General Notice,2006-08-03T04:00:00Z,2006,8,2006-08-02T04:00:00Z,2006-10-03T03:59:59Z,2025-12-18T20:15:37Z,,0,0,090000648045cbbd
FDA-2006-E-0319-0004,FDA,FDA-2006-E-0319,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2006-07-28T04:00:00Z,2006,7,,,2025-12-18T20:14:15Z,,0,0,090000648045cbbb
FDA-2006-E-0319-0003,FDA,FDA-2006-E-0319,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2006-06-21T04:00:00Z,2006,6,,,2025-12-18T20:09:37Z,,0,0,090000648045cbb9
FDA-2006-E-0319-0002,FDA,FDA-2006-E-0319,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2006-05-22T04:00:00Z,2006,5,,,2025-12-18T20:07:28Z,,0,0,090000648045cbb8
FDA-2006-E-0319-0001,FDA,FDA-2006-E-0319,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2006-05-05T04:00:00Z,2006,5,,,2025-12-18T20:04:32Z,,0,0,090000648045cb99